Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis
Psoriasis (PsO) is a chronic inflammatory dermatosis that often presents with erythematous, sharply demarcated lesions. Although psoriasis is primarily a dermatological disease, its immune-mediated pathogenesis produces systemic effects and is closely associated with various comorbid conditions such...
Saved in:
Main Authors: | Elena Campione (Author), Nikkia Zarabian (Author), Terenzio Cosio (Author), Cristiana Borselli (Author), Fabio Artosi (Author), Riccardo Cont (Author), Roberto Sorge (Author), Ruslana Gaeta Shumak (Author), Gaetana Costanza (Author), Antonia Rivieccio (Author), Roberta Gaziano (Author), Luca Bianchi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
by: Elena Campione, et al.
Published: (2023) -
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses
by: Elena Campione, et al.
Published: (2023) -
Retinoids in Fungal Infections: From Bench to Bedside
by: Terenzio Cosio, et al.
Published: (2021) -
Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016) -
Apremilast for lithium-associated psoriasis
by: Joohyung Youh, et al.
Published: (2022)